CRISPR Therapeutics AG

Jimi Olaghere Opens Up About His Sickle Cell...

May. 11, 2022

Sickle cell disease (SCD) is associated with lowered blood and oxygen flow, which leads to a range of symptoms and life-limiting complications....

Clinical Trial Roundup: Gene-Editing Therapies for...

Apr. 6, 2022

In this update, we summarise the two ongoing gene-editing clinical trials for renal cell carcinoma, which is the most common form of kidney cancer...

CRISPR Clinical Trials – Latest News Updates

Dec. 1, 2021

This week’s CRISPR trial update brings you the latest developments from ongoing CRISPR clinical trials, including expansion of Intellia Therapeutics’...

Disease Roundup: Sickle Cell Disease and CRISPR

Nov. 24, 2021

This up-to-date roundup presents the 7 clinical-stage gene-editing approaches to sickle cell disease, which affects millions of people worldwide and...

CMN Weekly (19 November 2021) - Your Weekly CRISPR...

Nov. 19, 2021

Some of the best links we picked up around the internet

First CRISPR Therapy for Type 1 Diabetes Set to...

Nov. 17, 2021

CRISPR Therapeutics and ViaCyte announced yesterday that Canada’s medical agency Health Canada has approved their clinical trial application for...

News: CMN Weekly (22 October 2021)

Oct. 22, 2021

Some of the best links we picked up around the internet

CMN Weekly (15 October 2021)

Oct. 15, 2021

Some of the best links we picked up around the internet